Statistics

Total Visits

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study56

Select a period of time:

Number of views in the range

Views
A randomised, double-blind, parallel-group, phase 1 study comparing the pharmacokinetics, safety and efficacy of ct-p13 and infliximab in patients with active ankylosing spondylitis: 54 week results from the planetas study35

Views

Views
December 20240
January 20250
February 20250
March 202518
April 202512
May 20255
June 20250
Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore17
Hong Kong11
United States2
Finland2
Germany1
Spain1
Mexico1
 

Top cities views

Views
Hong Kong11
Turku2
Cabo San Lucas1
Council Bluffs1
Los Angeles1
Nuremberg1